Cargando…
Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
Historically, the effort by academia and industry to develop new chemical entities into lifesaving drugs has limited success in meeting the demands of today’s healthcare. Repurposing drugs that are originally approved by the United States Food and Drug Administration or by regulatory authorities aro...
Autores principales: | Dalwadi, Shraddha M., Hunt, Andrew, Bonnen, Mark D., Ghebre, Yohannes T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233043/ https://www.ncbi.nlm.nih.gov/pubmed/37274281 http://dx.doi.org/10.3389/fonc.2023.1198284 |
Ejemplares similares
-
Proton pump inhibitors and sensitization of cancer cells to radiation therapy
por: Hebert, Kassidy A., et al.
Publicado: (2022) -
Emerging target discovery and drug repurposing opportunities in chordoma
por: Freed, Daniel M., et al.
Publicado: (2022) -
Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
por: Krendyukov, Andriy
Publicado: (2020) -
Silent Neoplastic Cardiac Invasion in Small Cell Lung Cancer: A Case Report and Review of the Literature
por: Pham, Ngoc, et al.
Publicado: (2018) -
Halal cultivated meat: an untapped opportunity
por: Attwood, Sophie, et al.
Publicado: (2023)